-
More Duchenne MD Mutations Corrected with New CRISPR Strategy
A new approach to CRISPR-Cas9 gene-editing technology called myoediting successfully restored dystrophin production and the force of contraction in heart muscle cells of DMD patients. Click here to read more about it.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.